Lipocine
LPCN
LPCN
38 hedge funds and large institutions have $10M invested in Lipocine in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0.61% → 0.61% (+0%)
22% less capital invested
Capital invested by funds: $12.8M → $10M (-$2.76M)
Holders
38
Holding in Top 10
–
Calls
$1.68M
Puts
$225K
Top Buyers
| 1 | +$196K | |
| 2 | +$190K | |
| 3 | +$98.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$61K |
Top Sellers
| 1 | -$391K | |
| 2 | -$220K | |
| 3 | -$77K | |
| 4 |
Bank of New York Mellon
New York
|
-$59.8K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$52K |